Company news Archives - EpitogenX

Lyme Tests Launch

August 13, 2024

Next Generation Lyme Diagnostics: Multi-Peptide Approach

Point-of-care and screening tests for early detection of Type 1 Diabetes

September 8, 2023

EpitoPredikt® and EpitoGen® combine to develop a diagnostic test for Lyme Disease (LD)

EpitoPredikt – Ongoing projects

January 12, 2023

EpitoPredikt and EpitoGen® Technologies have been applied in the development of an epitope-based SARS-CoV-2 serology test with 99% accuracy

December 7, 2022